Extemporaneous Formulations: Filling the Gap in the Pharmaceutical Industry with Personalized Medicines
A special issue of Pharmaceutics (ISSN 1999-4923). This special issue belongs to the section "Clinical Pharmaceutics".
Deadline for manuscript submissions: 31 December 2024 | Viewed by 39
Special Issue Editors
Interests: drug delivery; drug targeting; TSPO; imaging; tumors
Special Issues, Collections and Topics in MDPI journals
Interests: drug delivery; nanotechology; drug stability; paediatric formulation
Special Issues, Collections and Topics in MDPI journals
Special Issue Information
Dear Colleagues,
Extemporaneous pharmaceutical formulations refer to customized medications prepared on demand by pharmacists or healthcare professionals to meet specific patient requirements, constituting a personalized medicine. These formulations offer flexibility in terms of dosage, ingredients, and administration routes, and are tailored to individual patient needs. Moreover, advancements in compounding techniques and technology enhance the quality, safety, and consistency of the preparations.
Key factors driving innovation in extemporaneous formulations include advancements in pharmacotherapy, regulatory frameworks accommodating compounding practices, and collaborations between healthcare professionals and pharmaceutical stakeholders. Additionally, patient-centric approaches and personalized medicine trends further promote the adoption of extemporaneous formulations in clinical practice.
Despite the potential benefits, challenges such as standardization, quality control, and scalability need to be addressed to ensure widespread adoption and acceptance. Overall, innovation in pharmaceutical compounding represents a promising avenue for filling the void left by the absence of industrial medicines, particularly in underserved regions, thereby improving access to essential healthcare interventions and promoting better health outcomes for diverse patient populations.
In the realm of pharmaceuticals, the absence of industrially manufactured medicines poses significant challenges, especially in regions with limited access to healthcare infrastructure. However, innovation in pharmaceutical compounding emerges as a promising solution to bridge this gap.
This Special Issue explores the landscape of custom medications as a viable alternative to address the unmet medical needs resulting from the absence of commercial pharmaceuticals.
We welcome original research, reviews, opinion papers, editorials, or short communications on the following topics:
- Extemporaneous formulations;
- Off-label use;
- Orphan drugs;
- Dosage forms and excipients;
- Stability and compatibility;
- Compounding technologies;
- Compounding legislation and regulation;
- Quality control.
Prof. Dr. Nunzio Denora
Dr. Antonio Lopalco
Guest Editors
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Pharmaceutics is an international peer-reviewed open access monthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2900 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
Keywords
- extemporaneous
- compounding
- pharmaceutical
- formulation
- personalized
- pharmacy
